Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Olema Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 91 | 3 | 76 | −12 |
| Shares | 36.4M | 268.1K | 34.2M | −1.90M (−5.3%) |
| Value | $155.2M | $1.14M | $139.2M | −$14.8M (−9.6%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Newtyn Management, LLC | 500,000 | $2.04M | 0.39% |
| Laurion Capital Management LP | 495,300 | $2.02M | 0.08% |
| EcoR1 Capital, LLC | 353,701 | $1.44M | 0.05% |
| Tang Capital Management LLC | 318,926 | $1.30M | 0.20% |
| Marshall Wace, LLP | 137,466 | $558.0K | 0.00% |
| Monaco Asset Management SAM | 130,000 | $529.0K | 0.24% |
| New York Life Investment Management LLC | 109,469 | $446.0K | 0.01% |
| Cornercap Investment Counsel Inc | 51,152 | $208.0K | 0.04% |
| Bank of Montreal | 46,200 | $203.0K | 0.00% |
| Qube Research & Technologies Ltd | 25,315 | $103.0K | 0.00% |
| Bailard, Inc. | 22,400 | $91.0K | 0.00% |
| XTX Topco Ltd | 16,607 | $68.0K | 0.03% |
| HSBC Holdings PLC | 10,150 | $42.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 10,429 | $42.0K | 0.00% |
| Crewe Advisors LLC | 314 | $1.00K | 0.00% |
| Credit Suisse AG | 14 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 31 | $0 | 0.00% |
Sold out (29)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (3)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 173,761 | $740.0K |
| IndexIQ Advisors LLC | 90,750 | $387.0K |
| Amalgamated Financial Corp. | 3,542 | $15.0K |